Leidos Stock Drops After Bank of America Downgrades Outlook
Leidos stock fell nearly 11% this week following a downgrade from Bank of America, which cut its price target due to concerns over the company's healthcare business. The firm cited increased pressure on Leidos' healthcare portfolio as the U.S. Defense Health Agency shifts operations.
Topics: healthcare business pressure price target revision stock price movement